Gene Signal: Gene Signal Announces Positive Data From Phase 3 Trial of Aganirsen Eye Drops For Corneal Neovascularisation Due To Inflammation, A Rare Eye Disease With European Orphan Drug Designation

/www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup" ALT"free biotech news">/enewsletters.biospace.com/images/news/cta-latest-biotech-news.jpg" ALIGN"bottom" USEMAP"#cta-BiotechNews" border"0" alt"Get the latest biotech news where you want it. Sign up for the...